186 related articles for article (PubMed ID: 18498239)
1. Detection of epithelial-cell injury, and quantification of infection, in the HCT-8 organoid model of cryptosporidiosis.
Alcantara Warren C; Destura RV; Sevilleja JE; Barroso LF; Carvalho H; Barrett LJ; O'Brien AD; Guerrant RL
J Infect Dis; 2008 Jul; 198(1):143-9. PubMed ID: 18498239
[TBL] [Abstract][Full Text] [Related]
2. Neonatal Mouse Gut Metabolites Influence Cryptosporidium parvum Infection in Intestinal Epithelial Cells.
VanDussen KL; Funkhouser-Jones LJ; Akey ME; Schaefer DA; Ackman K; Riggs MW; Stappenbeck TS; Sibley LD
mBio; 2020 Dec; 11(6):. PubMed ID: 33323514
[TBL] [Abstract][Full Text] [Related]
3. Host cell tropism underlies species restriction of human and bovine Cryptosporidium parvum genotypes.
Hashim A; Clyne M; Mulcahy G; Akiyoshi D; Chalmers R; Bourke B
Infect Immun; 2004 Oct; 72(10):6125-31. PubMed ID: 15385517
[TBL] [Abstract][Full Text] [Related]
4. Induction of Inflammatory Responses in Splenocytes by Exosomes Released from Intestinal Epithelial Cells following
Wang Y; Shen Y; Liu H; Yin J; Zhang XT; Gong AY; Chen X; Chen S; Mathy NW; Cao J; Chen XM
Infect Immun; 2019 Apr; 87(4):. PubMed ID: 30642905
[No Abstract] [Full Text] [Related]
5. Investigations of the relationship between use of in vitro cell culture-quantitative PCR and a mouse-based bioassay for evaluating critical factors affecting the disinfection performance of pulsed UV light for treating Cryptosporidium parvum oocysts in saline.
Garvey M; Farrell H; Cormican M; Rowan N
J Microbiol Methods; 2010 Mar; 80(3):267-73. PubMed ID: 20096310
[TBL] [Abstract][Full Text] [Related]
6. [Highly Active AntiRetroviral Therapy and cryptosporidiosis].
Morales Gomez MA
Parassitologia; 2004 Jun; 46(1-2):95-9. PubMed ID: 15305695
[TBL] [Abstract][Full Text] [Related]
7. Novel Bioengineered Three-Dimensional Human Intestinal Model for Long-Term Infection of Cryptosporidium parvum.
DeCicco RePass MA; Chen Y; Lin Y; Zhou W; Kaplan DL; Ward HD
Infect Immun; 2017 Mar; 85(3):. PubMed ID: 28052996
[No Abstract] [Full Text] [Related]
8. Cryptosporidium parvum is cytopathic for cultured human biliary epithelia via an apoptotic mechanism.
Chen XM; Levine SA; Tietz P; Krueger E; McNiven MA; Jefferson DM; Mahle M; LaRusso NF
Hepatology; 1998 Oct; 28(4):906-13. PubMed ID: 9755224
[TBL] [Abstract][Full Text] [Related]
9. Assessment of Cryptosporidium parvum infection in immunocompetent and immunocompromised mice and its role in triggering intestinal dysplasia.
Abdou AG; Harba NM; Afifi AF; Elnaidany NF
Int J Infect Dis; 2013 Aug; 17(8):e593-600. PubMed ID: 23291034
[TBL] [Abstract][Full Text] [Related]
10. Interferon-λ3 Promotes Epithelial Defense and Barrier Function Against Cryptosporidium parvum Infection.
Ferguson SH; Foster DM; Sherry B; Magness ST; Nielsen DM; Gookin JL
Cell Mol Gastroenterol Hepatol; 2019; 8(1):1-20. PubMed ID: 30849550
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of attachment and internalization of Cryptosporidium parvum to biliary and intestinal epithelial cells.
Chen XM; LaRusso NF
Gastroenterology; 2000 Feb; 118(2):368-79. PubMed ID: 10648465
[TBL] [Abstract][Full Text] [Related]
12. Decreased SLC26A3 expression and function in intestinal epithelial cells in response to
Kumar A; Jayawardena D; Anbazhagan AN; Chatterjee I; Priyamvada S; Alrefai WA; Borthakur A; Dudeja PK
Am J Physiol Cell Physiol; 2019 Dec; 317(6):C1205-C1212. PubMed ID: 31483700
[TBL] [Abstract][Full Text] [Related]
13. Labeling surface epitopes to identify Cryptosporidium life stages using a scanning electron microscopy-based immunogold approach.
Edwards H; Thompson RC; Koh WH; Clode PL
Mol Cell Probes; 2012 Feb; 26(1):21-8. PubMed ID: 22100878
[TBL] [Abstract][Full Text] [Related]
14. Interaction of Cryptosporidium hominis and Cryptosporidium parvum with primary human and bovine intestinal cells.
Hashim A; Mulcahy G; Bourke B; Clyne M
Infect Immun; 2006 Jan; 74(1):99-107. PubMed ID: 16368962
[TBL] [Abstract][Full Text] [Related]
15. Bovine antibody against Cryptosporidium parvum elicits a circumsporozoite precipitate-like reaction and has immunotherapeutic effect against persistent cryptosporidiosis in SCID mice.
Riggs MW; Cama VA; Leary HL; Sterling CR
Infect Immun; 1994 May; 62(5):1927-39. PubMed ID: 8168959
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis of Cryptosporidium parvum infection.
Laurent F; McCole D; Eckmann L; Kagnoff MF
Microbes Infect; 1999 Feb; 1(2):141-8. PubMed ID: 10594978
[TBL] [Abstract][Full Text] [Related]
17. Bovine Cryptosporidium parvum field isolates differ in cytopathogenicity in HCT-8 monolayers.
Holzhausen I; Lendner M; Daugschies A
Vet Parasitol; 2019 Sep; 273():67-70. PubMed ID: 31442896
[TBL] [Abstract][Full Text] [Related]
18. An in vitro model of infection of human biliary epithelial cells by Cryptosporidium parvum.
Verdon R; Keusch GT; Tzipori S; Grubman SA; Jefferson DM; Ward HD
J Infect Dis; 1997 May; 175(5):1268-72. PubMed ID: 9129102
[TBL] [Abstract][Full Text] [Related]
19. Studying Cryptosporidium Infection in 3D Tissue-derived Human Organoid Culture Systems by Microinjection.
Dutta D; Heo I; O'Connor R
J Vis Exp; 2019 Sep; (151):. PubMed ID: 31566619
[TBL] [Abstract][Full Text] [Related]
20. Cryptosporidium parvum infection of human intestinal epithelial cells induces the polarized secretion of C-X-C chemokines.
Laurent F; Eckmann L; Savidge TC; Morgan G; Theodos C; Naciri M; Kagnoff MF
Infect Immun; 1997 Dec; 65(12):5067-73. PubMed ID: 9393797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
